Should We Reevaluate Liver Transplantation as an Alternative to Resection for the Treatment of Intrahepatic Cholangiocarcinoma?
Guergana G. Panayotova, James V. Guarrera, Keri E. Lunsford – 16 April 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Daniel S. Pratt, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Verna, Rohit Loomba, David E. Cohen, Jorge A. Bezerra, K. Rajender Reddy, Raymond T. Chung – 16 April 2020
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
Ligong Lu, Jun Jiang, Meixiao Zhan, Hui Zhang, Qian‐Ting Wang, Sheng‐Nan Sun, Xiao‐Kai Guo, Hua Yin, Yadong Wei, Jun O. Liu, Shi‐You Li, Yong Li, You‐Wen He – 16 April 2020
Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation
Siamak Salehi, Oliver D. Tavabie, Suman Verma, Mark J. W. McPhail, Farzin Farzaneh, William Bernal, Krish Menon, Kosh Agarwal, Varuna R. Aluvihare – 16 April 2020 – We previously demonstrated a distinct hepatic microRNA (miRNA) signature (down‐regulation of miRNA‐23a, ‐150, ‐ 200b, ‐503, and ‐663 and up‐regulation of miRNA‐20a) is associated with successful regeneration in auxiliary liver transplantation (ALT). This study aimed to evaluate whether the serum expression of this regeneration‐linked miRNA signature is associated with clinical outcomes in acute and chronic liver disease.
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Daniel S. Pratt, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Verna, Rohit Loomba, David E. Cohen, Jorge A. Bezerra, K. Rajender Reddy, Raymond T. Chung – 16 April 2020
Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?
- Read more about Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?
Steven M. Johnson, Katrina A. McGinty, Paul H. Hayashi, Eizaburo Sasatomi – 15 April 2020
Sodium‐Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes
Iaarah Montalvo‐Gordon, Luis Alberto Chi‐Cervera, Guadalupe García‐Tsao – 15 April 2020
The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction
Junbin Zhou, Jian Chen, Qiang Wei, Kourosh Saeb‐Parsy, Xiao Xu – 15 April 2020 – Liver transplantation (LT) is the only available curative treatment for patients with end‐stage liver disease. Early allograft dysfunction (EAD) is a life‐threatening complication of LT and is thought to be mediated in large part through ischemia/reperfusion injury (IRI). However, the underlying mechanisms linking IRI and EAD after LT are poorly understood.
Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation
Lei Zhang, Ruifeng Tian, Xinxin Yao, Xiao‐Jing Zhang, Peng Zhang, Yongping Huang, Zhi‐Gang She, Hongliang Li, Yan‐Xiao Ji, Jingjing Cai – 15 April 2020